C12N 5/0694
Cells of blood
Official title: {Cells of blood, e.g. leukemia cells, myeloma cells}
C12N5/0694 (Cells of blood) appears on 160 US grants and 224 published applications in this corpus.
Search patents in C12N- Granted patents
- 160
- Published applications
- 224
- Assignees
- 139
- Inventors
- 489
- Latest grant
- 31 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 3 | 0 |
| 1994 | 2 | 0 |
| 1995 | 2 | 0 |
| 1996 | 6 | 0 |
| 1997 | 3 | 0 |
| 1998 | 1 | 0 |
| 1999 | 2 | 0 |
| 2000 | 2 | 0 |
| 2001 | 3 | 1 |
| 2002 | 6 | 3 |
| 2003 | 2 | 4 |
| 2004 | 4 | 4 |
| 2005 | 2 | 5 |
| 2006 | 2 | 5 |
| 2007 | 0 | 5 |
| 2008 | 0 | 2 |
| 2009 | 3 | 5 |
| 2010 | 5 | 4 |
| 2011 | 5 | 11 |
| 2012 | 2 | 6 |
| 2013 | 8 | 8 |
| 2014 | 9 | 11 |
| 2015 | 4 | 7 |
| 2016 | 8 | 16 |
| 2017 | 12 | 13 |
| 2018 | 4 | 10 |
| 2019 | 9 | 17 |
| 2020 | 10 | 15 |
| 2021 | 6 | 13 |
| 2022 | 7 | 13 |
| 2023 | 8 | 7 |
| 2024 | 6 | 16 |
| 2025 | 7 | 12 |
| 2026 | 3 | 11 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Haematopoietic stem cell treatment31 Mar 2026US 12,589,115 B2The University Court of the University of Edinburgh
- Methods for performing miniaturized dynamic assays using microfluidics and related systems31 Mar 2026US 12,590,952 B2Biobridge Global
- Compositions and methods for delivery of immune cells to treat un-resectable or non-resected tumor cells and tumor relapse24 Mar 2026US 12,584,114 B2Fred Hutchinson Cancer Center
- Bioengineered wharton's jelly derived extracellular matrix18 Nov 2025US 12,472,282 B2University of Rochester
- Method, system, and filtration unit for the isolation of particles from biological samples7 Oct 2025US 12,434,175 B2Yantai Ausbio Laboratories Co., Ltd.
- Compositions and methods for delivery of immune cells to treat un-resectable or non-resected tumor cells and tumor relapse8 Oct 2026US 2026/0308532 A1Fred Hutchinson Cancer Center
- A Vaccine Composition of Cells Expressing a Lentiviral Vector and Methods of Using27 Aug 2026US 2026/0250717 A1Meridian Therapeutics, Inc.
- Microcapsule crosslinking23 Jul 2026US 2026/0209689 A1Droplet Genomics, UAB
- Methods for culturing cells and uses thereof9 Jul 2026US 2026/0193615 A1Acrocyte Therapeutics Inc.
- Medium and device for collecting, storing and transporting biological samples, as well as their use for the stabilization of extracellular nucleic acids9 Jul 2026US 2026/0193618 A1
Most cited
By later US patents
- Artificial antigen presenting cells and uses therefor105US 7,754,482 B2The Trustees of the University of Pennsylvania · 2010
- Artificial antigen presenting cells and uses therefor76US 8,722,400 B2The Trustees of the University of Pennsylvania · 2014
- Methods of treating acute myeloid leukemia by blocking CD4775US 8,562,997 B2The Board of Trustees of the Leland Stanford Junior University · 2013
- Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of T-lymphocytes, compositions containing same71US 5,474,771 AThe Trustees of Columbia University in the City of New York · 1995
- Method for isolating dendritic cells64US 5,643,786 AThe United States of America as represented by the Department of Health and Human Services · 1997